113 related articles for article (PubMed ID: 15778093)
41. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
Dinkel RE; Barrett PH; Demant T; Parhofer KG
Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
[TBL] [Abstract][Full Text] [Related]
42. Functional involvement of scavenger receptor class B, type I, in the uptake of alpha-tocopherol using cultured rat retinal capillary endothelial cells.
Tachikawa M; Okayasu S; Hosoya K
Mol Vis; 2007 Oct; 13():2041-7. PubMed ID: 18079677
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
[TBL] [Abstract][Full Text] [Related]
44. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711
[TBL] [Abstract][Full Text] [Related]
45. Quantification of apolipoprotein E receptors in human brain-derived cell lines by real-time polymerase chain reaction.
Thilakawardhana S; Everett DM; Murdock PR; Dingwall C; Owen JS
Neurobiol Aging; 2005 Jun; 26(6):813-23. PubMed ID: 15718039
[TBL] [Abstract][Full Text] [Related]
46. Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism.
Hirano K; Ikegami C; Tsujii K; Zhang Z; Matsuura F; Nakagawa-Toyama Y; Koseki M; Masuda D; Maruyama T; Shimomura I; Ueda Y; Yamashita S
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2422-7. PubMed ID: 16151015
[TBL] [Abstract][Full Text] [Related]
47. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
48. [The ratios of apoC-III/apoC-II in normal full-term maternal bloods and their umbilical cord bloods].
Ikeda H; Ikeda T
Rinsho Byori; 2001 Jan; 49(1):45-50. PubMed ID: 11215483
[TBL] [Abstract][Full Text] [Related]
49. Post-transcriptional regulation of apoC-I synthesis and secretion in human HepG2 cells.
Bouchard C; Dubuc G; Davignon J; Bernier L; Cohn JS
Atherosclerosis; 2005 Feb; 178(2):257-64. PubMed ID: 15694932
[TBL] [Abstract][Full Text] [Related]
50. Impact of vitamin A on high-density lipoprotein-cholesterol and scavenger receptor class BI in the obese rat.
Jeyakumar SM; Vajreswari A; Giridharan NV
Obesity (Silver Spring); 2007 Feb; 15(2):322-9. PubMed ID: 17299104
[TBL] [Abstract][Full Text] [Related]
51. Protective effect of apolipoprotein A I, A II, C I and C II on endothelial cells injury induced by low density lipoprotein.
Li J; Jiang L; Liu Q
Chin Med J (Engl); 1998 Jan; 111(1):78-81. PubMed ID: 10322661
[TBL] [Abstract][Full Text] [Related]
52. Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity.
Gautier T; Masson D; de Barros JP; Athias A; Gambert P; Aunis D; Metz-Boutigue MH; Lagrost L
J Biol Chem; 2000 Dec; 275(48):37504-9. PubMed ID: 10978346
[TBL] [Abstract][Full Text] [Related]
53. CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis.
Thorne RF; Mhaidat NM; Ralston KJ; Burns GF
FEBS Lett; 2007 Mar; 581(6):1227-32. PubMed ID: 17346709
[TBL] [Abstract][Full Text] [Related]
54. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques.
Svensson PA; Englund MC; Snäckestrand MS; Hägg DA; Ohlsson BG; Stemme V; Mattsson-Hulten L; Thelle DS; Fagerberg B; Wiklund O; Carlsson LM; Carlsson B
BMC Cardiovasc Disord; 2005 Aug; 5():25. PubMed ID: 16122381
[TBL] [Abstract][Full Text] [Related]
55. Apoc-III-beta-galactosidase hybrid distinguishes between VLDL and LDL phospholipids.
Trieu VN; McConathy WJ
Biochem Biophys Res Commun; 1995 Jun; 211(3):754-60. PubMed ID: 7598703
[TBL] [Abstract][Full Text] [Related]
56. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
57. [Separation and purification of human apolipoproteins A-I and C-III by chromatofocusing].
Cheng B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):280-5. PubMed ID: 8168208
[TBL] [Abstract][Full Text] [Related]
58. Visualization of the uptake of individual HDL particles in living cells via the scavenger receptor class B type I.
Rhode S; Breuer A; Hesse J; Sonnleitner M; Pagler TA; Doringer M; Schütz GJ; Stangl H
Cell Biochem Biophys; 2004; 41(3):343-56. PubMed ID: 15509885
[TBL] [Abstract][Full Text] [Related]
59. Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol.
Gillard BK; Rosales C; Pillai BK; Lin HY; Courtney HS; Pownall HJ
Biochemistry; 2010 Nov; 49(45):9866-73. PubMed ID: 20879789
[TBL] [Abstract][Full Text] [Related]
60. A role for scavenger receptor B-I in selective transfer of rhodamine-PE from liposomes to cells.
Yan X; Poelstra K; Scherphof GL; Kamps JA
Biochem Biophys Res Commun; 2004 Dec; 325(3):908-14. PubMed ID: 15541376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
